The International Society for the Study of Xenobiotics (ISSX) is a community of accomplished researchers and future scientists from academia and industry collaborating to advance the collective knowledge of xenobiotics. The program will cover toxicology, pharmacology, molecular biology, and other related disciplines.
Meet with our scientists at the ISSX/MDO joint meeting.
Poster Presentation Validation of an MFLC-MS/MS Assay for the Quantitative Analysis of a Novel Peptide, AT-01, Extracted from K2EDTA Plasma
Tara O’Brien (Presenter), Chad Christianson, Daniel Kim, Sangeetha Bollini, Andrew Vick
The Boston Society focuses on bringing the best scientific ideas to industrial practice. The annual forum on Applied Pharmaceutical Analysis is a full-spectrum program of activities encompassing mechanistic understanding, facets of development processes, and the technologies necessary to discover and develop novel therapeutic entities.
Engage with our scientific team for insightful discussions.
Panel Discussion ICH:M10 Brian Booth, Malaz Abutarif, Jennifer Zimmer, Jenifer Vija, and Salahedin Hamed
Monday, September 19, 2022
Session 1: 10:05-10:30 AM
Silver Sponsor Booth #3
September 19-21, 2022
The Workshop on Recent Issues in Bioanalysis (WRIB) showcases industry leaders and regulators, providing insights into emerging approaches to innovative science and the latest advice on evolving regulations. The organization promotes the exchange of knowledge and sharing of ideas through presentations of novel case studies with open discussion groups in a social setting.
September 26-30, 2022
Accurate and Precise Quantitation of the Phosphorothioate Oligonucleotide Mipomersen from Human Plasma by MFLC-MS/MS
Chad Christianson, TIDES USA: Oligonucleotide and Peptide Therapeutics Abstract | Poster | Tech Note
Communication Skills Promote Compliant Outcomes Rachel Walker, RQAP-GLP, 38th Society of Quality Assurance Annual Meeting & Quality College Abstract | Poster
Developing a Rugged Chiral Assay for the Biomarker 2-Hydroxyglutaric Acid for Use in Routine Clinical Analysis of Plasma Samples from Oncology Studies Presented by Jennifer Zimmer, PhD, Applied Pharmaceutical Analysis Abstract | Slides | Video Presentation